Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-25-009703
Filing Date
2025-03-10
Accepted
2025-03-10 16:20:54
Documents
76
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 2128825
2 ex23-1.htm EX-23.1 3729
3 ex31-1.htm EX-31.1 19337
4 ex31-2.htm EX-31.2 19331
5 ex32-1.htm EX-32.1 7786
6 ex32-2.htm EX-32.2 7753
7 form10-k_001.jpg GRAPHIC 81090
8 form10-k_002.jpg GRAPHIC 85784
  Complete submission text file 0001493152-25-009703.txt   7979517

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE ensc-20241231.xsd EX-101.SCH 43615
10 XBRL CALCULATION FILE ensc-20241231_cal.xml EX-101.CAL 60289
11 XBRL DEFINITION FILE ensc-20241231_def.xml EX-101.DEF 212969
12 XBRL LABEL FILE ensc-20241231_lab.xml EX-101.LAB 442025
13 XBRL PRESENTATION FILE ensc-20241231_pre.xml EX-101.PRE 353320
78 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 914266
Mailing Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037
Business Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037 (858) 263-4196
Ensysce Biosciences, Inc. (Filer) CIK: 0001716947 (see all company filings)

EIN.: 822755287 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38306 | Film No.: 25724003
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)